Innovating Works

AGENTSCHAP COLLEGE TER BEOORDELING VAN G...

Desconocido
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the... AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the dr...
2023-11-17 - 2027-12-31 | Financiado
EPND: European platform for neurodegenerative disorders AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage Alzheimer’s disease (AD) and Parkinson’s disease (PD) are common neurodegenerative conditions, posing a major societal burden. There is a la...
2021-10-25 - 2026-10-31 | Financiado
Gravitate-Health: Gravitate Health Empowering and Equipping Europeans with health information for Active Personal Hea... The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsiv...
2020-11-12 - 2025-10-31 | Financiado
UNICOM: Up scaling the global univocal identification of medicines AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-SC1-DTH-2018-2020 This innovation action will give a powerful impulse to implementation of ISO IDMP (ID of Medicinal Products) standards in EU Member States d...
2019-11-11 - 2024-05-31 | Financiado
RADAR-AD: Remote Assessment of Disease and Relapse Alzheimer s Disease AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage There is an urgent need for novel approaches assessing functional decline in early AD. The main goal of the RADAR-AD project is to develop a...
2018-12-05 - 2023-06-30 | Financiado
STARS: Strengthening training of academia in regulatory sciences and supporting regulatory scientific advic... AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-SC1-BHC-2018-2020 Lack of specific relevant know-how in regulatory science delays the development of new treatment strategies or limits the chances that promi...
2018-11-20 - 2022-06-30 | Financiado
ROADMAP: Real world Outcomes across the AD spectrum for better care Multimodal data Access Platform Sofia... AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage The aim of ROADMAP is to provide the foundation for a Europe-wide real world evidence (RWE) platform in AD by piloting multi-modal data inte...
2016-12-21 - 2018-10-31 | Financiado
VAC2VAC: Vaccine lot to Vaccine lot comparison by consistency testing. AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the l...
2016-04-14 - 2022-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.